Impact of definitive radiotherapy on metabolic response measured with 68Ga‐PSMA‐PET/CT in patients with intermediate‐risk prostate cancer
Cem Onal,
Ozan C. Guler,
Nese Torun
et al.
Abstract:PurposeTo assess the early metabolic response of the primary tumor using Gallium‐68 (68Ga)‐labeled‐prostate‐specific membrane antigen positron emission tomography (68Ga‐PSMA‐PET/CT), as well as the relationship between PSMA change in the primary tumor and PSA response after definitive radiotherapy (RT), either alone or in combination with androgen deprivation therapy (ADT) in intermediate risk prostate cancer (IR‐PCa) patients.MethodsThe clinical data of 71 IR‐PCa patients treated with RT alone (36 patients, 5… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.